New FDA-approved Alzheimer’s drug would cost $56,000 a year - Morning Briefing - Marketplace Minute - June 8, 2021

Shares of drugmaker Biogen rise 38%; Apple’s new privacy feature won’t be available in China; Colonial Pipeline CEO to testify in Congress To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices